>350 genes 1 |
Primary mitochondrial disorders
| AD AR Mat XL | Lactate & pyruvate concentrations are ↑; lactate-to-pyruvate ratio is ↑, often >20 |
BTD
|
Biotinidase deficiency
| AR | Can present in neonatal period or later in infancy w/neurologic symptoms such as lethargy, seizures w/metabolic acidosis, hearing loss, alopecia, & perioral/facial dermatitis Laboratory findings incl metabolic ketolactic acidosis, organic aciduria, & hyperammonemia If diagnosed through newborn screening, usually asymptomatic w/lifelong treatment of oral biotin
|
CA5A
|
Carbonic anhydrase VA deficiency
| AR | Neonatal, infantile, or early-childhood metabolic hyperammonemic encephalopathy combined w/lactic acidosis |
>30 genes | Organic acidemias (incl propionic acidemia, isolated methylmalonic acidemia, disorders of intracellular cobalamin metabolism, & other organic acidemias) | AR XL | Can present in neonatal period or later in infancy w/neurologic symptoms such as lethargy, encephalopathy, seizure, & metabolic acidosis &/or metabolic stroke Lactic acidemia, hypoglycemia, hyperammonemia, ketosis Multiorgan system involvement
|
DLAT
DLD
PDHA1
PDHB
PDHX
PDK3
PDP1
| Primary pyruvate dehydrogenase complex deficiency (PDCD) | AR XL | Lactic acidemia w/progressive or intermittent neurologic features (poor acquisition or loss of motor milestones, hypotonia, epilepsy, ataxia), nystagmus, & dystonia ↑ blood & CSF lactate concentrations & ↑ blood & CSF concentrations of pyruvate & alanine Blood ketone bodies usually not detectable & normal lactate-to-pyruvate ratio in plasma, unlike PC deficiency
|
Disorders assoc w/secondary PDCD that are phenotypically similar to primary PDCD
|
OLA3
IBA57
ISCA1
ISCA2
NFU1
PMPCB
| Multiple mitochondrial dysfunction syndromes (MMDS) (See ISCA1-MMDS & ISCA2-MMDS.) | AR |
|
ECHS1
|
Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency
| AR | Lactic acidosis ↑ pyruvate concentration (lactate-to-pyruvate ratio may be normal) May be assoc w/abnormal acylcarnitine profile &/or ↑ urine organic acid w/marked 2-methyl-2,3-dihydroxybutyric acid
|
HIBCH
| 3-hydroxyisobutyryl-CoA hydrolase deficiency (OMIM 250620) | AR |
|
LIAS
| Lipoic acid synthetase deficiency (OMIM 614462) | AR | Lactic acidosis & seizures ↑ pyruvate concentration (lactate-to-pyruvate ratio may be normal or elevated) ↑ glycine concentration Electron transport chain enzyme activity deficiencies
|
LIPT1
| Lipoyltransferase 1 deficiency (OMIM 616299) |
LIPT2
| Lipoyltransferase 2 deficiency (OMIM 617668) |
SLC25A1
| Mitochondrial citrate carrier deficiency (combined D-2- & L-2-hydroxyglutaric aciduria) (OMIM 615182) | AR |
|
TPK1
| Thiamine pyrophosphokinase deficiency (thiamine metabolism dysfunction syndrome 5, episodic encephalopathy type) (OMIM 614458) | AR |
|
Gluconeogenic disorders
|
FBP1
|
Fructose-1,6-bisphosphatase deficiency
| AR |
|
G6PC3
| G6PC3 deficiency (ubiquitous glucose-6-phosphatase deficiency) |
PCK1
| Phosphoenolpyruvate carboxykinase deficiency, cytosolic (OMIM 261680) |
Tricarboxylic acid cycle (TCA) disorders
|
FH
|
Fumarate hydratase deficiency
| AR | ↑ lactate & pyruvate concentrations ↑ lactate-to-pyruvate ratio ↑ fumaric acid or other TCA cycle intermediates
|
OGDH
| Oxoglutarate dehydrogenase deficiency (OMIM 203740) |
SDHA
SDHAF1
SDHB
SDHD
| Mitochondrial complex II deficiency, nuclear type (OMIM PS252011) |
SUCLA2
|
SUCLA2-related mitochondrial DNA depletion syndrome, encephalomyopathic form w/methylmalonic aciduria
|
Defects of ketone body utilization or transport
|
OXCT1
| Succinyl-CoA:3-oxoacid CoA transferase (SCOT) (OMIM 245050) | AR | Severe ketoacidosis, metabolic acidosis, tachypnea (due to acidosis), vomiting May have seizures May be hypo- or hyperglycemic or have mild hyperammonemia
|
ACAT1
| Mitochondrial acetoacetyl-CoA thiolase (T2) (OMIM 203750) |
SLC16A1
| Moncarboxylate transporter (MCT1) deficiencies (OMIM 616095) |